Market Currents
Johnson & Johnson (JNJ -0.3%) lags the general market after being downgraded to Market...
-
Thursday, February 2, 2012, 11:08 AM ETJohnson & Johnson (JNJ -0.3%) lags the general market after being downgraded to Market Perform on relative valuation at First Global. The firm says JNJ's overall performance in Q4 was a mixed bag and the company's likely to level off in its growth trajectory over the near term.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 2 comments:
However if you think it is time to protect gains JNJ might be a good choice.
Just dont think it is going to rocket up!
With Weldon as the CEO it is worth 80% of true value. Apparently he still has products to screw up. Several of them have not yet caused severe devastation. Meanwhile the BOD thinks it is safe even given its gross incompetence and failure to uphold reasonable diligence of duty.